09 October 2015

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
Futura Medical plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached  
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  
An event changing the breakdown of voting rights  
Other (please specify):    
3. Full name of person(s) subject to the
notification obligation:
Henderson Global Investors
4. Full name of shareholder(s)
(if different from 3.):
 
5. Date of the transaction and date on which the threshold is crossed orreached: 7 October 2015
6. Date on which issuer notified: 8 October 2015
7. Threshold(s) that is/are crossed or reached: Above 19%

8. Notified details:
A: Voting rights attached to shares
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights
Direct Direct Indirect Direct Indirect
Ordinary

GB0033278473
17,834,126 17,834,126     18,848,039   19.03%

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ Conversion Period Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
         

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date Exercise/
Conversion period
Number of voting rights instrument refers to % of voting rights
          Nominal Delta
   

Total (A+B+C)
Number of voting rights Percentage of voting rights
18,848,039 19.03%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
 
 
Proxy Voting:
10. Name of the proxy holder:  
11. Number of voting rights proxy holder will cease to hold:  
12. Date on which proxy holder will cease to hold voting rights:  
 
13. Additional information: This disclosure has been calculated based on total voting rights amount of 99,022,600.
14. Contact name: Scott Dickenson
15. Contact telephone number: 020 7818 4184

 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000